Vanderbilt researchers study ivermectin as potential COVID-19 treatment | Health

NASHVILLE, TN (WSMV) – Vanderbilt University Medical Center is seeking people to participate in a study to see if ivermectin and other drugs can treat COVID-19.

Ivermectin is a drug commonly used to treat parasitic infections, especially in livestock. Could it be a treatment for COVID-19 in humans?

Carolyn Coleman was diagnosed with COVID in early November, a day before she was due to receive her booster shot.

“I’ve been doubly vaccinated,” Coleman said. “I want to do everything I can to advance science and help people, you know, stay healthy.”

While Coleman has COVID-19, she decided to participate in the Activ-6 remote study and help COVID-19 in the long run. In the study, several hundred people across the country will receive one of the three drugs.

  • ivermectin
  • Fluvoamine (an antidepressant)
  • Fluticasone (treatment of asthma)
  • Participants can also receive a placebo

Coleman said she was on fluticasone.

‘I didn’t choose that one. It was chosen for me,” Coleman said.

“There’s so much misinformation about ivermectin out there,” said Dr. Parul Goyal, the principal investigator in the study at Vanderbilt.

She said most of the people taking part in the study are interested in ivermectin.

“The dose of ivermectin we’re using in the study is a relatively lower dose, and it’s a weight-based prescription,” Goyal said.

Goyal said ivermectin comes in a pill intended for humans. It is only 7 milligrams compared to what is given to animals such as horses.

“Ivermectin that was available to livestock is much more dangerous,” Goval said. “The side effects are much more because the dose is highly concentrated.”

“I don’t feel any worse, but I was on the mend anyway,” Coleman said.

She said she didn’t notice any difference in her symptoms with fluticasone, but she wouldn’t say no to ivermectin.

“I don’t know anything about ivermectin. I would have taken it because it was the deal I made with the research,” Coleman said.

To participate in the study, you must be at least 30 years old and have two symptoms related to COVID-19. To sign up, go to the website or call 615-343-8010.

WSMV.com is on the road with you now! Get the latest news updates and video, 4WARN weather forecast, weather radar, special investigation reports, sports headlines and much more from News4 Nashville.

>> Click/tap here to download our free mobile app. <

Copyright 2021 WSMV (Meredith Corporation). All rights reserved.


You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *